Kengo Watanabe

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 11, 2019
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.

Ryohei Katayama, Bo Gong, Noriko Togashi

Pageof 1

Frequent Collaborators

1 joint publications

Ryohei Katayama

1 joint publications

Noriko Togashi

1 joint publications

Satoshi Yoda

1 joint publications

Takeshi Isoyama